Laura B Teal
Lecturer I of Molecular and Integrative Physiology
[email protected]

Available to mentor

Laura B Teal
Lecturer
  • About
  • Qualifications
  • Recent Publications
  • About

    Scientific Writing Specialist for the U of M MS in Physiology. Ph.D. from Vanderbilt University in Pharmacology.

    Qualifications
    • Ph.D.
      Vanderbilt University, Nashville, 2023
    • B.S.
      Hope College, Holland, 2017
    • B.A.
      Hope College, Holland, 2017
    Recent Publications See All Publications
    • Journal Article
      Selective M5 muscarinic acetylcholine receptor negative allosteric modulator VU6008667 blocks acquisition of opioid self-administration.
      Teal LB, Bubser M, Duncan E, Gould RW, Lindsley CW, Jones CK. Neuropharmacology, 2023 Apr 1; 227: 109424 DOI:10.1016/j.neuropharm.2023.109424
      PMID: 36720403
    • Journal Article
      Acute Negative Allosteric Modulation of M5 Muscarinic Acetylcholine Receptors Inhibits Oxycodone Self-Administration and Cue-Induced Reactivity with No Effect on Antinociception.
      Gould RW, Gunter BW, Bubser M, Matthews RT, Teal LB, Ragland MG, Bridges TM, Garrison AT, Winder DG, Lindsley CW, Jones CK. ACS Chem Neurosci, 2019 Aug 21; 10 (8): 3740 - 3750. DOI:10.1021/acschemneuro.9b00274
      PMID: 31268669
    • Chapter
      Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders.
      Teal LB, Gould RW, Felts AS, Jones CK. Adv Pharmacol, 2019 86: 153 - 196. DOI:10.1016/bs.apha.2019.05.001
      PMID: 31378251
    • Journal Article
      M1/M4-Preferring Muscarinic Cholinergic Receptor Agonist Xanomeline Reverses Wake and Arousal Deficits in Nonpathologically Aged Mice.
      Russell JK, Ingram SM, Teal LB, Lindsley CW, Jones CK. ACS Chem Neurosci, 2023 Feb 1; 14 (3): 435 - 457. DOI:10.1021/acschemneuro.2c00592
      PMID: 36655909
    • Chapter
      The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders.
      Teal LB, Ingram SM, Bubser M, McClure E, Jones CK. Adv Neurobiol, 2023 30: 37 - 99. DOI:10.1007/978-3-031-21054-9_3
      PMID: 36928846
    • Journal Article
      Development of VU6019650: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M5 Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder.
      Garrison AT, Orsi DL, Capstick RA, Whomble D, Li J, Carter TR, Felts AS, Vinson PN, Rodriguez AL, Han A, Hajari K, Cho HP, Teal LB, Ragland MG, Ghamari-Langroudi M, Bubser M, Chang S, Schnetz-Boutaud NC, Boutaud O, Blobaum AL, Foster DJ, Niswender CM, Conn PJ, Lindsley CW, Jones CK, Han C. J Med Chem, 2022 Apr 28; 65 (8): 6273 - 6286. DOI:10.1021/acs.jmedchem.2c00192
      PMID: 35417155
    • Journal Article
      Superior Colliculus Lesions Lead to Disrupted Responses to Light in Diurnal Grass Rats (Arvicanthis niloticus).
      Gall AJ, Goodwin AM, Khacherian OS, Teal LB. J Biol Rhythms, 2020 Feb; 35 (1): 45 - 57. DOI:10.1177/0748730419881920
      PMID: 31619104
    • Journal Article
      Selective M5 muscarinic acetylcholine receptor negative allosteric modulator VU6008667 blocks acquisition of opioid self-administration.
      Teal LB, Bubser M, Duncan E, Gould RW, Lindsley CW, Jones CK. Neuropharmacology, 2023 Apr 1; 227: 109424 DOI:10.1016/j.neuropharm.2023.109424
      PMID: 36720403